GRI

Announcements

Nothing here yet

Daily updates

Nothing here yet

FDA designations

Nothing here yet

News

• GRI Bio secured FDA Orphan Drug Designation for GRI-0621 (tazarotene) in idiopathic pulmonary fibrosisJun 18, 2026
• GRI Bio received UAE patent allowance for novel NKT cell agonists targeting inflammatory diseasesApr 8, 2026
• GRI Bio delivered Phase 2a data showing fibrosis improvements in IPF patientsJan 28, 2026
• GRI Bio reports 6-week interim lung function data in ongoing Phase 2a study in idiopathic pulmonary fibrosis (IPF)Sep 11, 2025
• GRI Bio reports 6-week interim biomarker data in ongoing Phase 2a study for idiopathic pulmonary fibrosis (IPF)Jul 31, 2025